| scholarly article | Q13442814 |
| P50 | author | Shilpa Buch | Q37368426 |
| Minglei Guo | Q81891869 | ||
| P2093 | author name string | Honghong Yao | |
| Tsung-Ping Su | |||
| Vijeta Singh | |||
| John Wang | |||
| Tomohisa Mori | |||
| Pankaj Seth | |||
| Blaise Mathias-Costa | |||
| P2860 | cites work | Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine | Q24796371 |
| Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures | Q28330757 | ||
| Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro | Q28354326 | ||
| Cocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120 | Q28475805 | ||
| Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability | Q28587728 | ||
| Molecular basis for interactions of HIV and drugs of abuse. | Q30332159 | ||
| Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules | Q31398002 | ||
| The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells | Q31557057 | ||
| New Evidence on Intravenous Cocaine Use and the Risk of Infection with Human Immunodeficiency Virus Type 1 | Q33283034 | ||
| Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke | Q33610598 | ||
| Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways | Q33799365 | ||
| Pathobiology of human immunodeficiency virus dementia | Q33863784 | ||
| Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration | Q33931800 | ||
| Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia | Q34098776 | ||
| Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia | Q34196506 | ||
| Pathways to neuronal injury and apoptosis in HIV-associated dementia. | Q34223078 | ||
| Microbial Infections, Immunomodulation, and Drugs of Abuse | Q34926928 | ||
| Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. | Q35009483 | ||
| Cocaine use and HIV infection in intravenous drug users in San Francisco | Q36416785 | ||
| Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis | Q36418584 | ||
| Neuropathology of Human Immunodeficiency Virus Infection | Q36476918 | ||
| Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: A study with rat cerebellar granule cell cultures | Q36695384 | ||
| The Neuropathology of HIV/AIDS. | Q37073650 | ||
| Evolution of HIV dementia with HIV infection | Q37073653 | ||
| μ-opioid modulation of HIV-1 coreceptor expressionand HIV-1 replication | Q38355088 | ||
| Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain | Q39310058 | ||
| Influence of HAART on HIV-related CNS disease and neuroinflammation. | Q40411104 | ||
| Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome | Q40604776 | ||
| Entangled epidemics: cocaine use and HIV disease | Q40789555 | ||
| Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. | Q41063277 | ||
| Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. | Q41841039 | ||
| Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine | Q42286432 | ||
| Upregulation of microglia in drug users with and without pre-symptomatic HIV infection | Q42479974 | ||
| Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum | Q42493967 | ||
| Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function | Q42527671 | ||
| Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects | Q42538818 | ||
| Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? | Q42541038 | ||
| Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations | Q43070999 | ||
| Cocaine activates redox-regulated transcription factors and induces TNF-alpha expression in human brain endothelial cells | Q43804903 | ||
| Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes | Q43896579 | ||
| Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. | Q44809348 | ||
| Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. | Q45759401 | ||
| Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. | Q45763749 | ||
| Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. | Q46152124 | ||
| Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor | Q46873640 | ||
| Cocaine enhances brain endothelial adhesion molecules and leukocyte migration | Q48225755 | ||
| The neuropathology of adult HIV infection. | Q48291701 | ||
| Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. | Q48704471 | ||
| A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis | Q48743313 | ||
| Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse | Q49133762 | ||
| Correlates of HIV infection among young adult short-term injection drug users. | Q50659913 | ||
| Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. | Q51562087 | ||
| Cocaine suppresses proliferation of phytohemagglutinin-activated human peripheral blood T-cells. | Q51674574 | ||
| HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998 | Q57446072 | ||
| Human immunodeficiency virus and the central nervous system | Q67587480 | ||
| Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack) | Q68028828 | ||
| The neuropathogenesis of HIV-1 infection | Q72182527 | ||
| Marijuana and cocaine impair alveolar macrophage function and cytokine production | Q73885929 | ||
| Acute and chronic effects of cocaine on the immune system and the possible link to AIDS | Q74608049 | ||
| A prospective study of HIV disease progression in female and male drug users | Q77323334 | ||
| P433 | issue | 5 | |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 425-428 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Current HIV Research | Q5195049 |
| P1476 | title | Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms | |
| P478 | volume | 10 |
| Q52689726 | Astrocytic metabolic switch is a novel etiology for Cocaine and HIV-1 Tat-mediated neurotoxicity. |
| Q26825762 | Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence |
| Q36985189 | Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation. |
| Q40145747 | Cocaine and HIV are independently associated with neural activation in response to gain and loss valuation during economic risky choice. |
| Q47866273 | Cocaine and HIV-1 Tat disrupt cholesterol homeostasis in astrocytes: Implications for HIV-associated neurocognitive disorders in cocaine user patients. |
| Q51336032 | Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes. |
| Q37141770 | Cocaine induces astrocytosis through ER stress-mediated activation of autophagy |
| Q36565777 | Cocaine-mediated induction of microglial activation involves the ER stress-TLR2 axis |
| Q36111649 | Cocaine-mediated microglial activation involves the ER stress-autophagy axis. |
| Q38259808 | Development of in vivo drug-induced neurotoxicity models. |
| Q40354055 | Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis |
| Q34504916 | Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress |
| Q37019304 | Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages |
| Q28260551 | Effect of mild-to-moderate smoking on viral load, cytokines, oxidative stress, and cytochrome P450 enzymes in HIV-infected individuals |
| Q97516540 | Effects of Drugs of Abuse on the Blood-Brain Barrier: A Brief Overview |
| Q37184831 | HIV and Cocaine Impact Glial Metabolism: Energy Sensor AMP-activated protein kinase Role in Mitochondrial Biogenesis and Epigenetic Remodeling |
| Q99728806 | HIV-Tat and Cocaine Impact Brain Energy Metabolism: Redox Modification and Mitochondrial Biogenesis Influence NRF Transcription-Mediated Neurodegeneration |
| Q27015965 | HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities |
| Q26779435 | Impact of cocaine abuse on HIV pathogenesis |
| Q35181162 | Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States |
| Q35007339 | Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors |
| Q89796139 | Male HIV-1 transgenic rats show reduced cocaine-maintained lever-pressing compared to F344 wildtype rats despite similar baseline locomotion |
| Q33815611 | Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse |
| Q99419745 | Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior |
| Q47329696 | Network Analysis of Hippocampal Neurons by Microelectrode Array in the Presence of HIV-1 Tat and Cocaine |
| Q28247084 | Neuroimmune basis of methamphetamine toxicity |
| Q41067770 | Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study |
| Q37721505 | Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND. |
| Q40111779 | Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS. |
| Q36091506 | Psychostimulant Abuse and HIV Infection: cocaine, methamphetamine, and "bath salts" cathinone analogues |
| Q33920251 | Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders |
| Q34247817 | Substance use in older HIV-infected patients |
| Q26824282 | Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesis |
| Q58753178 | The "Frail" Brain Blood Barrier in Neurodegenerative Diseases: Role of Early Disruption of Endothelial Cell-to-Cell Connections |
| Q34675713 | The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems. |
| Q26782833 | Vitamin D receptor and epigenetics in HIV infection and drug abuse |
| Q57821144 | Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions |
Search more.